PTTandINRLaboratorytests used tomanagetherapeuticrange ofwarfarinPlasminogenAn inactive proteinpresent in many bodytissues and fluids thatis bound to fibrin andbecomes acomponent of a bloodclotDVTand PEHeparin isgivenprophylacticallyto patients toprevent theseClopidogrelprototype Adenosinediphosphate receptorantagonist thatirreversibly blocks theADP receptor onplatelet cell surface.Rivaroxabandirect factor Xainhibitor prototypethat inhibits plateletactivation andformation of fibrinclotting by inhibitionof factor XaThrombolyticDrugsagentsthatdissolveblood clotsalteplaseprototypethrombolyticdrugtranexamicacidReversal ofthrombolytic agentused for short periodsin patients withhemophilia to preventor decrease breedingform tooth extraction ormenorrhagia.ThrombolysisDissolutionof bloodclotsHeparin inducedthrombocytopenia(HIT)A potentially life-threateningcomplication of heparinadministration leadingto a decrease inplatelet count anddetectable HITantibodiesHomeostasisProcess thatmaintains theintegrity ofthe vascularcompartment.PCCReversal ofwarfarin overdosewith acute majorbleeding or inneed of emergentsurgeryAminocaproicacidReversal ofthrombolytic agentused in cardiacsurgery, blooddisorders, hepaticcirrhosis,prostatectomy, andneoplastic disordersHeparininhibits theconversion ofprothrombin tothrombin andprevents thrombusformationaPTTlaboratory testused to see ifheparin iswithintherapeuticrangeHemorrhagemajor sideeffect ofHeparintherapyVitaminKantidoteforwarfarin3QSEN Alert: Thenurse should holdthe dose of warfarinif the INR is abovethis number andnotify the healthcare providerIdarucizumabAntidotefordabigatranProtamineSulfateAntidoteforheparinDisseminatedintravascularcoagulation(DIC)Heparin is used totreat this life-threatening conditioncharacterized bywidespread clotting,which depletes theblood of coagulationfactors.ActionofwarfarinActs in theliver topreventsynthesis ofvitamin KwarfarinPrototypevitamin KantagonistdabigatranThe onlyoral directthrombininhibitorPTTandINRLaboratorytests used tomanagetherapeuticrange ofwarfarinPlasminogenAn inactive proteinpresent in many bodytissues and fluids thatis bound to fibrin andbecomes acomponent of a bloodclotDVTand PEHeparin isgivenprophylacticallyto patients toprevent theseClopidogrelprototype Adenosinediphosphate receptorantagonist thatirreversibly blocks theADP receptor onplatelet cell surface.Rivaroxabandirect factor Xainhibitor prototypethat inhibits plateletactivation andformation of fibrinclotting by inhibitionof factor XaThrombolyticDrugsagentsthatdissolveblood clotsalteplaseprototypethrombolyticdrugtranexamicacidReversal ofthrombolytic agentused for short periodsin patients withhemophilia to preventor decrease breedingform tooth extraction ormenorrhagia.ThrombolysisDissolutionof bloodclotsHeparin inducedthrombocytopenia(HIT)A potentially life-threateningcomplication of heparinadministration leadingto a decrease inplatelet count anddetectable HITantibodiesHomeostasisProcess thatmaintains theintegrity ofthe vascularcompartment.PCCReversal ofwarfarin overdosewith acute majorbleeding or inneed of emergentsurgeryAminocaproicacidReversal ofthrombolytic agentused in cardiacsurgery, blooddisorders, hepaticcirrhosis,prostatectomy, andneoplastic disordersHeparininhibits theconversion ofprothrombin tothrombin andprevents thrombusformationaPTTlaboratory testused to see ifheparin iswithintherapeuticrangeHemorrhagemajor sideeffect ofHeparintherapyVitaminKantidoteforwarfarin3QSEN Alert: Thenurse should holdthe dose of warfarinif the INR is abovethis number andnotify the healthcare providerIdarucizumabAntidotefordabigatranProtamineSulfateAntidoteforheparinDisseminatedintravascularcoagulation(DIC)Heparin is used totreat this life-threatening conditioncharacterized bywidespread clotting,which depletes theblood of coagulationfactors.ActionofwarfarinActs in theliver topreventsynthesis ofvitamin KwarfarinPrototypevitamin KantagonistdabigatranThe onlyoral directthrombininhibitor

Chapter 9 Drug Therapy for Coagulation Disorders - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Laboratory tests used to manage therapeutic range of warfarin
    PTT and INR
  2. An inactive protein present in many body tissues and fluids that is bound to fibrin and becomes a component of a blood clot
    Plasminogen
  3. Heparin is given prophylactically to patients to prevent these
    DVT and PE
  4. prototype Adenosine diphosphate receptor antagonist that irreversibly blocks the ADP receptor on platelet cell surface.
    Clopidogrel
  5. direct factor Xa inhibitor prototype that inhibits platelet activation and formation of fibrin clotting by inhibition of factor Xa
    Rivaroxaban
  6. agents that dissolve blood clots
    Thrombolytic Drugs
  7. prototype thrombolytic drug
    alteplase
  8. Reversal of thrombolytic agent used for short periods in patients with hemophilia to prevent or decrease breeding form tooth extraction or menorrhagia.
    tranexamic acid
  9. Dissolution of blood clots
    Thrombolysis
  10. A potentially life-threatening complication of heparin administration leading to a decrease in platelet count and detectable HIT antibodies
    Heparin induced thrombocytopenia (HIT)
  11. Process that maintains the integrity of the vascular compartment.
    Homeostasis
  12. Reversal of warfarin overdose with acute major bleeding or in need of emergent surgery
    PCC
  13. Reversal of thrombolytic agent used in cardiac surgery, blood disorders, hepatic cirrhosis, prostatectomy, and neoplastic disorders
    Aminocaproic acid
  14. inhibits the conversion of prothrombin to thrombin and prevents thrombus formation
    Heparin
  15. laboratory test used to see if heparin is within therapeutic range
    aPTT
  16. major side effect of Heparin therapy
    Hemorrhage
  17. antidote for warfarin
    Vitamin K
  18. QSEN Alert: The nurse should hold the dose of warfarin if the INR is above this number and notify the health care provider
    3
  19. Antidote for dabigatran
    Idarucizumab
  20. Antidote for heparin
    Protamine Sulfate
  21. Heparin is used to treat this life-threatening condition characterized by widespread clotting, which depletes the blood of coagulation factors.
    Disseminated intravascular coagulation (DIC)
  22. Acts in the liver to prevent synthesis of vitamin K
    Action of warfarin
  23. Prototype vitamin K antagonist
    warfarin
  24. The only oral direct thrombin inhibitor
    dabigatran